PLUS THERAPEUTICS, INC. Files Form 8-K with SEC Detailing Shareholder Director Nomination Procedures and Company Information
Plus Therapeutics Announces Date and Details for 2026 Annual...
Sign in to continue:
Plus Therapeutics Announces Date and Details for 2026 Annual...
Turtle Beach Corporation Q4 and Full Year 2025 Financial Res...
TREASURE GLOBAL INC (TGL) - 8-K Filing: Key Details for Inve...
AMREP Corporation Reports Strong Q3 Fiscal 2026 Results ...
California BanCorp Declares Cash Dividend: Investor Report ...
Axcelis Announces CFO Transition and Interim Appointment ...
60 Degrees Pharmaceuticals, Inc. Files Updated Legal Opinion...
NCR Atleos Corporation Announces Successful Consent Solicita...
Surf Air Mobility Reports Q4 and FY2025 Results, Issues 2026...
CACI International Inc. Announces \$500 Million Add-On to 6....